Advertisement
Canada markets open in 3 hours 43 minutes
  • S&P/TSX

    22,269.12
    +197.42 (+0.89%)
     
  • S&P 500

    5,277.51
    +42.03 (+0.80%)
     
  • DOW

    38,686.32
    +574.82 (+1.51%)
     
  • CAD/USD

    0.7317
    -0.0022 (-0.30%)
     
  • CRUDE OIL

    77.13
    +0.14 (+0.18%)
     
  • Bitcoin CAD

    94,327.61
    +2,218.53 (+2.41%)
     
  • CMC Crypto 200

    1,487.10
    +19.16 (+1.31%)
     
  • GOLD FUTURES

    2,346.10
    +0.30 (+0.01%)
     
  • RUSSELL 2000

    2,070.13
    +13.53 (+0.66%)
     
  • 10-Yr Bond

    4.5140
    -0.0400 (-0.88%)
     
  • NASDAQ futures

    18,665.50
    +74.50 (+0.40%)
     
  • VOLATILITY

    13.26
    +0.34 (+2.63%)
     
  • FTSE

    8,289.89
    +14.51 (+0.18%)
     
  • NIKKEI 225

    38,923.03
    +435.13 (+1.13%)
     
  • CAD/EUR

    0.6751
    -0.0011 (-0.16%)
     

dentalcorp Holdings First Quarter 2024 Earnings: CA$0.062 loss per share (vs CA$0.18 loss in 1Q 2023)

dentalcorp Holdings (TSE:DNTL) First Quarter 2024 Results

Key Financial Results

  • Revenue: CA$372.4m (up 3.9% from 1Q 2023).

  • Net loss: CA$11.7m (loss narrowed by 65% from 1Q 2023).

  • CA$0.062 loss per share (improved from CA$0.18 loss in 1Q 2023).

earnings-and-revenue-growth
earnings-and-revenue-growth

All figures shown in the chart above are for the trailing 12 month (TTM) period

dentalcorp Holdings Earnings Insights

Looking ahead, revenue is forecast to grow 10% p.a. on average during the next 2 years, compared to a 8.8% growth forecast for the Healthcare industry in Canada.

Performance of the Canadian Healthcare industry.

The company's share price is broadly unchanged from a week ago.

Balance Sheet Analysis

While earnings are important, another area to consider is the balance sheet. See our latest analysis on dentalcorp Holdings' balance sheet health.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.